With this extension, IXCHIQ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU).
ABPI urges NHS investment, Jazz acquires Chimerix, AstraZeneca's $1bn bet, and NICE approves an endometriosis pill.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback